DeFi Daily News
Monday, June 30, 2025
Advertisement
  • Cryptocurrency
    • Bitcoin
    • Ethereum
    • Altcoins
    • DeFi-IRA
  • DeFi
    • NFT
    • Metaverse
    • Web 3
  • Finance
    • Business Finance
    • Personal Finance
  • Markets
    • Crypto Market
    • Stock Market
    • Analysis
  • Other News
    • World & US
    • Politics
    • Entertainment
    • Tech
    • Sports
    • Health
  • Videos
No Result
View All Result
DeFi Daily News
  • Cryptocurrency
    • Bitcoin
    • Ethereum
    • Altcoins
    • DeFi-IRA
  • DeFi
    • NFT
    • Metaverse
    • Web 3
  • Finance
    • Business Finance
    • Personal Finance
  • Markets
    • Crypto Market
    • Stock Market
    • Analysis
  • Other News
    • World & US
    • Politics
    • Entertainment
    • Tech
    • Sports
    • Health
  • Videos
No Result
View All Result
DeFi Daily News
No Result
View All Result
Home Markets Stock Market

Summary of Ocean Biomedical’s (NASDAQ: OCEA) Research Findings on AlphaStreet

Staff Correspondent by Staff Correspondent
August 23, 2024
in Stock Market
0 0
0
Summary of Ocean Biomedical’s (NASDAQ: OCEA) Research Findings on AlphaStreet
0
SHARES
0
VIEWS
Share on FacebookShare on TwitterShare on Telegram
Listen to this article


Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new therapeutic candidates efficiently from the laboratory to the clinic. Currently, it is developing five clinical discoveries with the potential to achieve transformative outcomes in cancer, pulmonary fibrosis, and malaria.

Quick Facts

Ocean Biomedical bets on its licensing and subsidiary structure to create mutual value for shareholders and licensing partners. It was founded by Dr. Chirinjeev Kathuria, who is also the executive chairman. Elizabeth Ng serves as the chief executive officer. The company became a public entity in February 2023, and the stock trades on the Nasdaq stock market under the symbol OCEA. It is headquartered in Providence, Rhode Island. Under its unique business model, Ocean Biomedical endeavors to expedite the development and commercialization of therapeutic candidates from research universities and medical centers.

Focus Areas

The company focuses on preclinical programs with the potential for wide application in the treatment of malaria, fibrosis, and various types of cancers.

Cancer Program: This includes immunotherapies for lung, brain, and other cancers. At the same time, scientists seek to understand the broad anti-tumor mechanisms behind the anti-CHi3L1 discoveries. Anti-CHi3L1 has been found effective in the treatment of brain cancer, creating a 60% reduction in tumor growth in the human glioblastoma multiforme stem cell model in vivo.

Malaria Program: The company is on a mission to find solutions to address the urgent global need to develop more effective therapies for malaria treatment. That includes advancing the knowledge and control of the mechanisms by which its PfGARP antigen induces malaria parasite death, as well as optimizing/developing an mRNA vaccine candidate based on discoveries of PfGARP, PfSEA, and another antigen that may be able to simultaneously target the malaria parasite at different stages of the blood cycle.

Fibrosis Program: This program addresses the standard of care and treatment options for patients suffering from Idiopathic Pulmonary Fibrosis. There are indications that Ocean Biomedical’s candidate for treating IPF might be effective against other fibrotic diseases. The progress achieved in the program includes testing the anti-fibrotic treatment candidate OCF-203, generating impressive reductions of fibrosis in multiple models, and reducing collagen accumulation by 85%-90%.

Latest Developments

A few months ago, Virion Therapeutics, Ocean Biomedical’s joint venture partner, presented the first-ever human immunogenicity data from its novel checkpoint modifier immunotherapy for HBV functional cure. Virion is a clinical-stage biotechnology company developing novel T cell-based immunotherapies. Earlier, the company’s scientific co-founder Dr. Jonathan Kurti received a new patent for his malaria therapeutic antibody discoveries, targeted to both prevent malaria infection and treat severe malaria.

Conclusion

Ocean Biomedical is well-positioned to take advantage of the growing demand for new and effective pharmaceutical products, driven in part by the aging population. The pharmaceutical industry is witnessing rapid digitization of the drug development process, a trend that can influence the company’s clinical trials and their outcomes. While Ocean Biomedical has an effective business model, future success would depend on how the company tackles the growing competition. For more trending news articles like this, visit DeFi Daily News.



Source link

Tags: AlphaStreetBiomedicalsFindingsnasdaqOCEAOceanResearchSummary
ShareTweetShare
Previous Post

WazirX Commences Phasing in Withdrawals in Indian Rupees from Aug. 26 | Coin Media

Next Post

RFK Jr. Halts Presidential Bid, Plans to Back Trump – Decrypt

Next Post
RFK Jr. Halts Presidential Bid, Plans to Back Trump – Decrypt

RFK Jr. Halts Presidential Bid, Plans to Back Trump - Decrypt

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
  • Trending
  • Comments
  • Latest
rewrite this title SEI Leads Crypto Market With 43% Weekly Surge – alt=

rewrite this title SEI Leads Crypto Market With 43% Weekly Surge – $0.5 Reclaim In The Horizon?

June 28, 2025
rewrite this title High Season, High Stakes: Navigating Summer Risks in Property Management

rewrite this title High Season, High Stakes: Navigating Summer Risks in Property Management

June 27, 2025
rewrite this title ‘FIFA Rivals’ Review: Should You Play This NFT Soccer Game? – Decrypt

rewrite this title ‘FIFA Rivals’ Review: Should You Play This NFT Soccer Game? – Decrypt

June 28, 2025
They’re Going ALL IN on Crypto: This is What Wall St is Buying!

They’re Going ALL IN on Crypto: This is What Wall St is Buying!

June 25, 2025
rewrite this title with good SEO Bitcoin Could Explode On Bessent’s 0 Billion Deregulation Shock

rewrite this title with good SEO Bitcoin Could Explode On Bessent’s $250 Billion Deregulation Shock

May 28, 2025
Crypto Analyst Reveals Six ‘Super-Cycle’ Tokens Set to Surge by 1000x in Value

Crypto Analyst Reveals Six ‘Super-Cycle’ Tokens Set to Surge by 1000x in Value

August 16, 2024
rewrite this title Inter Milan dumped out of Club World Cup by Fluminense in historic win

rewrite this title Inter Milan dumped out of Club World Cup by Fluminense in historic win

June 30, 2025
rewrite this title Why a GOP senator says the budget bill breaks Trump’s promise : Consider This from NPR

rewrite this title Why a GOP senator says the budget bill breaks Trump’s promise : Consider This from NPR

June 30, 2025
rewrite this title The 11+ best anti-Prime Day deals 2025 from Best Buy, Walmart, & more: Top sales from Amazon's competition

rewrite this title The 11+ best anti-Prime Day deals 2025 from Best Buy, Walmart, & more: Top sales from Amazon's competition

June 30, 2025
LeBron James Planning Trade From The Lakers?! | Pat McAfee Show

LeBron James Planning Trade From The Lakers?! | Pat McAfee Show

June 30, 2025
“All Hell Is Breaking Loose in Crypto.. Ethereum & Altcoins will make MILLIONAIRES” – Tom Lee

“All Hell Is Breaking Loose in Crypto.. Ethereum & Altcoins will make MILLIONAIRES” – Tom Lee

June 30, 2025
rewrite this title with good SEO Warning Signs? Long-Term Bitcoin Holders Take Profits as Leverage Spikes

rewrite this title with good SEO Warning Signs? Long-Term Bitcoin Holders Take Profits as Leverage Spikes

June 30, 2025
DeFi Daily

Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.

  • About Us
  • Blogs
  • DeFi-IRA | Learn More.
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Cryptocurrency
    • Bitcoin
    • Ethereum
    • Altcoins
    • DeFi-IRA
  • DeFi
    • NFT
    • Metaverse
    • Web 3
  • Finance
    • Business Finance
    • Personal Finance
  • Markets
    • Crypto Market
    • Stock Market
    • Analysis
  • Other News
    • World & US
    • Politics
    • Entertainment
    • Tech
    • Sports
    • Health
  • Videos

Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.